Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,123 across all filing types
Latest filing 2024-12-12 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM
Report Publication Announcement Classification · 1% confidence The document is a notification letter informing shareholders that certain corporate communications (a circular and proxy form) have been published on the company’s and Stock Exchange’s websites. It does not contain the substantive report itself but simply announces the availability of those materials online. Therefore, it is a Report Publication Announcement (RPA).
2024-12-12 English
DOCUMENTS ON DISPLAY
Regulatory Filings Classification · 1% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2024-12-12 English
NOTICE OF SPECIAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a notice of a special general meeting (SGM) including the resolution to be voted on, proxy appointment instructions, and meeting details. It is soliciting shareholder votes and providing information statements for the meeting, matching the definition of Proxy Solicitation & Information Statement (PSI).
2024-12-12 English
FORM OF PROXY FOR USE AT THE SPECIAL GENERAL MEETING TO BE HELD ON TUESDAY, 31 DECEMBER 2024 AT 10:00 A.M. (OR AT ANY ADJOURNED MEETING THEREOF)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a form of proxy for a special general meeting, providing shareholders with voting instructions and proxy appointment details. This is a solicitation material sent to shareholders to request their votes for resolutions at a meeting. It is not an announcement of a report, nor a full report itself. Therefore, it falls under Proxy Solicitation & Information Statement.
2024-12-12 English
(I) MAJOR AND CONTINUING CONNECTED TRANSACTIONS UNDER THE SERVICE AGREEMENT AND (II) NOTICE OF SPECIAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular issued by CMBC Capital Holdings Limited providing detailed background on connected transactions, the terms of a proposed Service Agreement, letters from the Board, the Independent Board Committee, an Independent Financial Adviser, and includes a Notice of Special General Meeting along with a proxy form. It is designed to solicit shareholder votes at the SGM and contains proxy instructions, meeting details, and explanatory statements. This closely matches the definition of a Proxy Solicitation & Information Statement (PSI).
2024-12-12 English
DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITIONS OF NOTES
Capital/Financing Update Classification · 1% confidence The document is a Hong Kong stock exchange announcement by CMBC Capital Holdings Limited regarding a “discloseable transaction” under the Listing Rules – namely the acquisition of US$8 million of perpetual notes. It outlines principal terms of the debt, listing rules implications, information on the issuer, reasons for the acquisition, and definitions. This is not an earnings release, annual or interim report, nor a share issuance or management changes. It is a financing‐related corporate transaction announcement and fits the “Capital/Financing Update” category (CAP).
2024-12-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.